ENHANCE: A randomized, double-blind, multicenter study comparing magrolimab in combination with azacitidine versus azacitidine plus placebo in treatment-naive patients with higher risk myelodysplastic syndrome

  • Kenealy, Melita (Primary Chief Investigator (PCI))
  • Baker, Emma (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date19/10/20 → 31/12/23

Keywords

  • Medical oncology
  • Myelodysplastic syndrome
  • Clinical trial